Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Total Debt (2021 - 2024)

Historic Total Debt for Roivant Sciences (ROIV) over the last 4 years, with Q2 2024 value amounting to $203.5 million.

  • Roivant Sciences' Total Debt fell 162.07% to $203.5 million in Q2 2024 from the same period last year, while for Jun 2024 it was $203.5 million, marking a year-over-year decrease of 162.07%. This contributed to the annual value of $200.7 million for FY2024, which is 1.44% up from last year.
  • Roivant Sciences' Total Debt amounted to $203.5 million in Q2 2024, which was down 162.07% from $200.7 million recorded in Q1 2024.
  • Roivant Sciences' Total Debt's 5-year high stood at $217.7 million during Q4 2023, with a 5-year trough of $32.6 million in Q1 2022.
  • Moreover, its 4-year median value for Total Debt was $200.3 million (2021), whereas its average is $175.3 million.
  • Per our database at Business Quant, Roivant Sciences' Total Debt crashed by 8212.83% in 2022 and then soared by 52121.67% in 2023.
  • Quarter analysis of 4 years shows Roivant Sciences' Total Debt stood at $204.0 million in 2021, then dropped by 4.39% to $195.1 million in 2022, then grew by 11.59% to $217.7 million in 2023, then fell by 6.51% to $203.5 million in 2024.
  • Its last three reported values are $203.5 million in Q2 2024, $200.7 million for Q1 2024, and $217.7 million during Q4 2023.